Your browser doesn't support javascript.
loading
IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.
Barone, Francesca; Nayar, Saba; Campos, Joana; Cloake, Thomas; Withers, David R; Toellner, Kai-Michael; Zhang, Yang; Fouser, Lynette; Fisher, Benjamin; Bowman, Simon; Rangel-Moreno, Javier; Garcia-Hernandez, Maria de la Luz; Randall, Troy D; Lucchesi, Davide; Bombardieri, Michele; Pitzalis, Costantino; Luther, Sanjiv A; Buckley, Christopher D.
Afiliação
  • Barone F; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Nayar S; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Campos J; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Cloake T; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Withers DR; School of infection and Immunity, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom;
  • Toellner KM; School of infection and Immunity, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom;
  • Zhang Y; School of infection and Immunity, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom;
  • Fouser L; Pfizer Research, Cambridge MA 02139-3526;
  • Fisher B; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Bowman S; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
  • Rangel-Moreno J; Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester, Rochester, NY 14642;
  • Garcia-Hernandez Mde L; Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester, Rochester, NY 14642;
  • Randall TD; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-2182;
  • Lucchesi D; Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, EC1M 6BQ, London United Kingdom;
  • Bombardieri M; Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, EC1M 6BQ, London United Kingdom;
  • Pitzalis C; Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, EC1M 6BQ, London United Kingdom;
  • Luther SA; Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland.
  • Buckley CD; Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, Uni
Proc Natl Acad Sci U S A ; 112(35): 11024-9, 2015 Sep 01.
Article em En | MEDLINE | ID: mdl-26286991
The series of events leading to tertiary lymphoid organ (TLO) formation in mucosal organs following tissue damage remain unclear. Using a virus-induced model of autoantibody formation in the salivary glands of adult mice, we demonstrate that IL-22 provides a mechanistic link between mucosal infection, B-cell recruitment, and humoral autoimmunity. IL-22 receptor engagement is necessary and sufficient to promote differential expression of chemokine (C-X-C motif) ligand 12 and chemokine (C-X-C motif) ligand 13 in epithelial and fibroblastic stromal cells that, in turn, is pivotal for B-cell recruitment and organization of the TLOs. Accordingly, genetic and therapeutic blockade of IL-22 impairs and reverses TLO formation and autoantibody production. Our work highlights a critical role for IL-22 in TLO-induced pathology and provides a rationale for the use of IL-22-blocking agents in B-cell-mediated autoimmune conditions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucinas / Quimiocinas CXC / Tecido Linfoide Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucinas / Quimiocinas CXC / Tecido Linfoide Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article